{
    "Trade/Device Name(s)": [
        "FORA V30 Blood Glucose Monitoring System",
        "TD-4242 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K093635",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090187"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "December 23, 2009",
    "Summary Letter Received Date": "January 20, 2010",
    "Submission Date": "11.20.2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FORA V30 Blood Glucose Meter",
        "TD-4242 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Glucose oxidase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control solution",
        "Lancing device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for FORA V30/TD-4242 Blood Glucose Monitoring System utilizing electrochemical biosensor technology for glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from finger or alternative sites by healthcare professionals and people with diabetes at home, as an aid in monitoring diabetes control; not for diagnosis/screening or neonatal use",
    "fda_folder": "Clinical Chemistry"
}